Karen S. Anderson

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 28 papers. Top paper: “Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations”.

Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations

ACS Central Science(2021)10.1021/acscentsci.1c00039

N/A

0.834DataRank · unranked

259 citations

Elizabeth A. Stone, M.G. Deshmukh, Joseph A. Ippolito, Mohammad Mehdi Ghahremanpour, Julian Tirado‐Rives +11 more

Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application

Blood(2002)10.1182/blood.v99.9.3319

N/A

0.789DataRank · unranked

191 citations

Robert H. Vonderheide, Britta Maecker, Naoto Hirano, Karen S. Anderson, Marcus O. Butler +6 more

A High-Throughput, High-Containment Human Primary Epithelial Airway Organ-on-Chip Platform for SARS-CoV-2 Therapeutic Screening

Cells(2023)10.3390/cells12222639

N/A

0.470DataRank · unranked

22 citations

Felix Mba Medie, Rebeccah J. Luu, Robert B. Gaibler, Thomas J. Mulhern, Caitlin R. Miller +14 more

Proof-of-concept studies with a computationally designed M pro inhibitor as a synergistic combination regimen alternative to Paxlovid

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2320713121

N/A

0.425DataRank · unranked

16 citations

Irfan Ullah, Amalendu P. Ranjan, Shuo Zhang, Qihao Wu, Krasimir A. Spasov +9 more

Post-Catalytic Complexes with Emtricitabine or Stavudine and HIV-1 Reverse Transcriptase Reveal New Mechanistic Insights for Nucleotide Incorporation and Drug Resistance

Molecules(2020)10.3390/molecules25204868

N/A

0DataRank · unranked

6 citations

Albert H. Chan, Raymond F. Schinazi, Karen S. Anderson, Nicole Bertoletti

Targeting the TS dimer interface in bifunctional Cryptosporidium hominis TS-DHFR from parasitic protozoa: Virtual screening identifies novel TS allosteric inhibitors

Bioorganic & Medicinal Chemistry Letters(2020)10.1016/j.bmcl.2020.127292

N/A

0DataRank · unranked

3 citations

Daniel J. Czyzyk, Vidya P. Kumar, William L. Jorgensen, Karen S. Anderson, Victor G. Ruiz

Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.28.271957

N/A

0DataRank · unranked

29 citations

Julian Tirado‐Rives, M.G. Deshmukh, Joseph A. Ippolito, Chunhui Zhang, Israel Cabeza de Vaca +4 more

Faculty Opinions recommendation of Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature(2020)10.3410/f.736585207.793570659

N/A

0DataRank · unranked

0 citations

Karen S. Anderson

Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease

Structure(2021)10.1016/j.str.2021.06.002

N/A

0DataRank · unranked

63 citations

Joseph A. Ippolito, Chunhui Zhang, Elizabeth A. Stone, R. Reilly, Scott J. Miller +3 more

Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency

ACS Medicinal Chemistry Letters(2021)10.1021/acsmedchemlett.1c00326

N/A

0DataRank · unranked

57 citations

Krasimir A. Spasov, R. Reilly, Klarissa Hollander, Elizabeth A. Stone, Joseph A. Ippolito +11 more

Covalent Inhibition of Wild-Type HIV-1 Reverse Transcriptase Using a Fluorosulfate Warhead

ACS Medicinal Chemistry Letters(2021)10.1021/acsmedchemlett.0c00612

N/A

0DataRank · unranked

28 citations

Haichan Niu, Nicole Bertoletti, Zachary J. Carter, Shengyan Jin, Krasimir A. Spasov +6 more

Platelet-derived growth factor receptor beta activates Abl2 via direct binding and phosphorylation

Journal of Biological Chemistry(2021)10.1016/j.jbc.2021.100883

N/A

0DataRank · unranked

5 citations

Hanzhi Wu, Wanqing Lyu, Young‐Joo Kim, Cristina M. Furdui, Karen S. Anderson +2 more

Genetic diversity and genetic relatedness in P. falciparum parasite population in individuals with uncomplicated malaria based on Microsatellite typing in Eastern and Western regions of Uganda, 2019-2020.

Research Square(2021)10.21203/rs.3.rs-305011/v1

N/A

0DataRank · unranked

0 citations

Karen S. Anderson, Karryn Gresty, Christiane Prosser, David J. Smith, Joaniter I. Nankabirwa +12 more

Structure-Guided Identification of DNMT3B Inhibitors

ACS Medicinal Chemistry Letters(2020)10.1021/acsmedchemlett.0c00011

N/A

0DataRank · unranked

20 citations

John C. Faver, Goran Micevic, Viswanathan Muthusamy, Shalley N. Kudalkar, Nicole Bertoletti +4 more

Structural Studies and Structure Activity Relationships for Novel Computationally Designed Non-nucleoside Inhibitors and Their Interactions With HIV-1 Reverse Transcriptase

Frontiers in Molecular Biosciences(2022)10.3389/fmolb.2022.805187

N/A

0DataRank · unranked

11 citations

Nicole Bertoletti, Albert H. Chan, Joseph A. Ippolito, Mariela Bollini, Krasimir A. Spasov +3 more

Defining the structure-activity relationship for a novel class of allosteric MKP5 inhibitors

European Journal of Medicinal Chemistry(2022)10.1016/j.ejmech.2022.114712

N/A

0DataRank · unranked

8 citations

Haya Jamali, Oh Sang Kweon, James Herrington, Shanelle R. Shillingford, Christina Papini +6 more

APOBEC mutagenesis and selection for NFE2L2 contribute to the origin of lung squamous-cell carcinoma

Lung Cancer(2022)10.1016/j.lungcan.2022.07.004

N/A

0DataRank · unranked

6 citations

Shalley N. Kudalkar, Krishna Dasari, Stephen G. Gaffney, Heather Lazowski, Laura Jackson +6 more

Covalent and noncovalent strategies for targeting Lys102 in HIV-1 reverse transcriptase

European Journal of Medicinal Chemistry(2023)10.1016/j.ejmech.2023.115894

N/A

0DataRank · unranked

9 citations

Sean Henry, Klarissa Hollander, Zachary J. Carter, Krasimir A. Spasov, William L. Jorgensen +2 more

Design, synthesis, and biological testing of biphenylmethyloxazole inhibitors targeting HIV-1 reverse transcriptase

Bioorganic & Medicinal Chemistry Letters(2023)10.1016/j.bmcl.2023.129216

N/A

0DataRank · unranked

6 citations

Klarissa Hollander, Krasimir A. Spasov, Karen S. Anderson, William L. Jorgensen, Zachary J. Carter

Exploring novel HIV‐1 reverse transcriptase inhibitors with drug‐resistant mutants: A double mutant surprise

Protein Science(2023)10.1002/pro.4814

N/A

0DataRank · unranked

6 citations

Albert H. Chan, Kathleen M. Frey, Olivia Hunker, Joseph A. Ippolito, Krasimir A. Spasov +5 more

Prodrug nanotherapy demonstrates in vivo anticryptosporidial efficacy in a mouse model of chronic Cryptosporidium infection

RSC Pharmaceutics(2024)10.1039/d4pm00093e

N/A

0DataRank · unranked

1 citations

Daniel J. Czyzyk, Griselle Martinez-Traverso, Aygül Sadıqova, Margarita Valhondo, Deborah A. Schaefer +7 more

Precision projections of the delay of resistance mutations in non-small cell lung cancer via suppression of APOBEC

Lung Cancer(2025)10.1016/j.lungcan.2025.108487

N/A

0DataRank · unranked

4 citations

Jeffrey D. Mandell, Karen S. Anderson, Jeffrey P. Townsend, Orestis Nousias

Exploring Possible Drug-Resistant Variants of SARS-CoV-2 Main Protease (Mpro) with Noncovalent Preclinical Candidate, Mpro61

ACS Bio & Med Chem Au(2025)10.1021/acsbiomedchemau.4c00109

N/A

0DataRank · unranked

1 citations

Christina Papini, Su Tang, Kathy Huynh, Chunhui Zhang, William L. Jorgensen +2 more

A virtual screening strategy to repurpose antifolate compounds as W. bancrofti DHFR inhibitors

Bioorganic & Medicinal Chemistry Letters(2025)10.1016/j.bmcl.2025.130370

N/A

0DataRank · unranked

0 citations

Jacquelyn Wilhelm, Merna Salama, Monika Salama, Klarissa Hollander, Karen S. Anderson +3 more

Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies

npj Precision Oncology(2022)10.1038/s41698-022-00320-5

N/A

0DataRank · unranked

19 citations

Zechen Wang, Min Lu, Annie Liu, David S. Hsu, Shannon J. McCall +6 more

Structural investigation of 2‐naphthyl phenyl ether inhibitors bound to WT and Y181C reverse transcriptase highlights key features of the NNRTI binding site

Protein Science(2020)10.1002/pro.3910

N/A

0DataRank · unranked

12 citations

Joseph A. Ippolito, Albert H. Chan, Won‐Gil Lee, Krasimir A. Spasov, William L. Jorgensen +2 more

Global Genome Demethylation Causes Transcription-Associated DNA Double Strand Breaks in HPV-Associated Head and Neck Cancer Cells

Cancers(2020)10.3390/cancers13010021

N/A

0DataRank · unranked

9 citations

Asel Biktasova, Andrew Sewell, Cyril Gary, Paul G. Cantalupo, Karen S. Anderson +2 more

Identifying the role of PrimPol in TDF-induced toxicity and implications of its loss of function mutation in an HIV+ patient

Scientific Reports(2020)10.1038/s41598-020-66153-z

N/A

0DataRank · unranked

26 citations

Lei Zhou, María I. Martínez-Jiménez, Linh He, Moises Cosme, Luis Blanco +3 more